Comparison between Globalspace Technologies IPO and Vaishali Pharma IPO.
Globalspace Technologies IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Vaishali Pharma IPO is a SME Bookbuilding proposed to list at NSE SME.
| Globalspace Technologies IPO | Vaishali Pharma IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Bookbuilding |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Choice Capital Advisors Pvt.Ltd. | Pantomath Capital Advisors Pvt.Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Choice Equity Broking Pvt.Ltd. | Pantomath Stock Brokers Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Globalspace Technologies IPO is up to ₹19.01 Cr whereas the issue size of the Vaishali Pharma IPO is up to ₹13.48 Cr. The final issue price of Globalspace Technologies IPO is ₹66.00 per share and of Vaishali Pharma IPO is ₹72.00 per share.
| Globalspace Technologies IPO | Vaishali Pharma IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹71.00 per share | |
| Issue Price (Upper) | ₹72.00 per share | |
| Issue Price (Final) | ₹66.00 per share | ₹72.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | 1600 shares |
| Fresh Issue Size | 28,80,000 shares | 18,72,000 shares |
| Fresh Issue Size (Amount) | up to ₹19.01 Cr | up to ₹13.48 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 28,80,000 shares | 18,72,000 shares |
| Issue Size Total (Amount) | up to ₹19.01 Cr | up to ₹13.48 Cr |
Globalspace Technologies IPO opens on Jul 26, 2017, while Vaishali Pharma IPO opens on Aug 07, 2017. The closing date of Globalspace Technologies IPO and Vaishali Pharma IPO is Jul 28, 2017, and Aug 10, 2017, respectively.
| Globalspace Technologies IPO | Vaishali Pharma IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jul 26, 2017 | Aug 07, 2017 |
| Issue Close | Jul 28, 2017 | Aug 10, 2017 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Aug 07, 2017 | Aug 22, 2017 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Globalspace Technologies IPO P/E ratio is , as compared to Vaishali Pharma IPO P/E ratio of .
| Globalspace Technologies IPO | Vaishali Pharma IPO | ||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials |
| ||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | |||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | |||||||||||||||||||||||||||||||||
| P/E Ratio | |||||||||||||||||||||||||||||||||
| Market Cap | |||||||||||||||||||||||||||||||||
| ROE | |||||||||||||||||||||||||||||||||
| ROCE | |||||||||||||||||||||||||||||||||
| Debt/Equity | |||||||||||||||||||||||||||||||||
| EPS | |||||||||||||||||||||||||||||||||
| RoNW | |||||||||||||||||||||||||||||||||
In the Globalspace Technologies IPO Retail Individual Investors (RII) are offered 14,40,000 shares while in Vaishali Pharma IPO retail investors are offered 14,40,000 shares. Qualified Institutional Buyers (QIB) are offered in Globalspace Technologies IPO and in Vaishali Pharma IPO.
| Globalspace Technologies IPO | Vaishali Pharma IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | 1,54,000 shares | 1,04,000 shares |
| QIB | ||
| NII | 14,40,000 shares | 9,36,000 shares |
| RII | 14,40,000 shares | 9,36,000 shares |
| Employee | ||
| Others | ||
| Total | 28,80,000 shares | 18,72,000 shares |
Globalspace Technologies IPO subscribed in total, whereas Vaishali Pharma IPO subscribed 1.89x.
| Globalspace Technologies IPO | Vaishali Pharma IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 1.87x | |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 1.91x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.89x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
